Драницына, М. А.
| Issue | Section | Title | Abstract | File |
| No 2 (2021) | Articles | Biosimilars: reproduction of the clinical profile using modern biotechnology | Abstract |
 (Rus) |
| No 3 (2021) | Articles | Biosimilars: evolution of approaches to the development, regulation, life cycle control and interchangeability management | Abstract |
(Rus) |
| No 3 (2019) | Articles | Properties of the two one-sided tests procedure for the bioequivalence assessment of medicinal products | Abstract |
(Rus) |
| No 5 (2019) | Articles | Issues of bringing the registration dossier in compliance with the requirements of the rules for registration and expertise in EAEU | Abstract |
(Rus) |
| No 5 (2018) | Articles | Issues of recognition of GLP-status of domestic test facilities and trials abroad | Abstract |
(Rus) |
| No 7-8 (2018) | Articles | Regulatory aspects of marketing authorization of generic and hybrid medicinal products in the Eurasian Economic Union | Abstract |
(Rus) |
| No 11 (2018) | Articles | Issues of breakthrough therapy and accelerated market authorization in Russia and the EAEU | Abstract |
(Rus) |